These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4773367)

  • 1. Behaviour of the portal clotting time in cats following the intraduodenal administration of heparin.
    Kokot B
    Thromb Diath Haemorrh; 1973 Nov; 30(2):284-8. PubMed ID: 4773367
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of heparin on the plasma fibrinolytic activity.
    Poplawski A; Glowínski S
    Acta Physiol Pol; 1974; 25(1):39-42. PubMed ID: 4281609
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
    Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
    Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of inferior vena caval occlusion to prevent pulmonary emboli.
    Davis WC; McManus WF; Freeman DE; LeVeen RF
    Am Surg; 1972 May; 38(5):268-73. PubMed ID: 5026669
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of heparin in the reflex reactions of blood coagulation].
    Kudriashov BA; Kalishevskaia TM; Kovaleva TN; Morozova GA
    Dokl Akad Nauk SSSR; 1969 Feb; 184(5):1239-42. PubMed ID: 5398177
    [No Abstract]   [Full Text] [Related]  

  • 6. [Control of heparin and oral anticoagulants, with micromethods: thrombin time, quick determination with addition of protamine].
    Seiler K; Müller G; Duckert F
    Schweiz Med Wochenschr; 1970 Sep; 100(36):1522-8. PubMed ID: 5524716
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of taurolidine on experimental thrombus formation.
    Kaptanoglu L; Kucuk HF; Colak E; Kurt N; Bingul SM; Akyol H; Torlak OA; Yazici F
    Eur J Pharmacol; 2008 Jan; 578(2-3):238-41. PubMed ID: 17961549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rabbit model allowing access to portal vein, vena cava, aorta and duodenum without anesthesia.
    Zysset T; Bieri HU; Probst P; Bircher J
    Arzneimittelforschung; 1981; 31(6):965-9. PubMed ID: 7196242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of aprotinin on heparinized whole blood activated clotting time and whole blood prothrombin time].
    Wen Z; Zhu F; He X; Xiong S; He S
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):304-6. PubMed ID: 9868081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of intratracheal administration of heparin on the status of the mast cell population in the rat].
    Orlova AG; Chernova OV; Rozkin MIa; Efimov VS
    Farmakol Toksikol; 1989; 52(3):55-9. PubMed ID: 2792355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a new potent heparin. 7th communication: A comparative study of a new potent heparin in human after i.v. application.
    Bhargava AS; Wendt H; Günzel P
    Arzneimittelforschung; 1981; 31(2):386-8. PubMed ID: 7194658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
    Greene CE; Meriwether E
    Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of surface induced coagulation by preadsorption of albumin-heparin conjugates.
    Hennink WE; Kim SW; Feijen J
    J Biomed Mater Res; 1984 Oct; 18(8):911-26. PubMed ID: 6544786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of the level of heparinization necessary to provide cascade filtration exchange plasmapheresis in patients with generalized suppurative peritonitis].
    Ender LA; Vatazin AV; Iunovidova LI
    Anesteziol Reanimatol; 1991; (1):35-7. PubMed ID: 1862961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and anticoagulation activity of sodium cellulose sulfate.
    Wang ZM; Li L; Zheng BS; Normakhamatov N; Guo SY
    Int J Biol Macromol; 2007 Oct; 41(4):376-82. PubMed ID: 17602735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Present state of heparin therapy].
    Blatrix C; Soulier JP; Vacheron A; Cornu P
    Presse Med (1893); 1969 Mar; 77(15):553-6. PubMed ID: 5796027
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin action on bleeding time and its rate of removal from blood in dogs and rabbits.
    Magalhães JR
    Acta Physiol Lat Am; 1969; 19(3):243-8. PubMed ID: 5374277
    [No Abstract]   [Full Text] [Related]  

  • 20. [Simple method for controlling anticoagulation with vitamin K antagonists during heparin therapy: rapid determination after heparin absorption by ECTEOLA cellulose].
    Schuler J; von Felten A
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1798-800. PubMed ID: 7178878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.